Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson's disease (PD).
- generic_name
- rivastigmine tartrate
- product_names
- RIVASTIGMINE TARTRATE
- ndc
- 33342-089, 33342-090, 33342-091, 33342-092, 33342-089-09, 33342-089-15, 33342-089-12, 33342-089-06, 33342-090-09, 33342-090-15, 33342-090-12, 33342-090-06, 33342-091-09, 33342-091-15, 33342-091-12, 33342-091-06, 33342-092-09, 33342-092-15, 33342-092-12, 33342-092-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en